Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS

Neuroscience

Volumn 100, Issue 1, 2000, Pages 141-153

  Abbadie, C ^a   Pan, Y X ^a   Drake, C T ^b   Pasternak, G W ^a  

^a Laboratory of Molecular Biophysics   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CNS; Immunohistochemistry; Mouse; mu opioid receptor; Splice variant

Indexed keywords

MU OPIATE RECEPTOR;

AMBIGUUS NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENTATE GYRUS; EXON; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFERIOR OLIVE; MALE; MOSSY FIBER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RNA SPLICING; SOLITARY TRACT NUCLEUS; SPINAL CORD; TRIGEMINAL NUCLEUS;

ANIMALS; CELL LINE; CENTRAL NERVOUS SYSTEM; DNA, COMPLEMENTARY; DNA, RECOMBINANT; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; PEPTIDE FRAGMENTS; RATS; RECEPTORS, OPIOID, MU; TISSUE DISTRIBUTION; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0034618846     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00248-7     Document Type: Article

References (62)

1. Abbadie C., Pan Y.-X., Pasternak G.W. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C- and MOR-1-like immunoreactivity: evidence for region-specific processing. J. comp. Neurol. 419:2000;244-256.
2. Arvidsson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A.H., Dado R.J., Loh H.H., Law P.-Y., Wessendorf M.W., Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
3. Bare L.A., Mansson E., Yang D. Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain. Fedn Eur. biochem. Socs Lett. 354:1994;213-216.
4. Besse D., Lombard M.C., Zajac J.M., Roques B.P., Besson J.M. Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521:1990;15-22.
5. Besson J.M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
6. Burstein R., Cliffer K.D., Giesler G.J. Jr. Direct somatosensory projections from the spinal cord to the hypothalamus and telencephalon. J. Neurosci. 7:1987;4159-4164.
7. Burstein R., Dado R.J., Giesler G.J. Jr. The cells of origin of the spinothalamic tract of the rat: a quantitative reexamination. Brain Res. 511:1990;329-337.
8. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Molec. Pharmac. 44:1993;8-12.
9. 5-enkephalin. J. comp. Neurol. 371:1996;522-536.
10. 5-enkephalin. Brain Res. 731:1996;141-154.
11. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of μ-opioid receptors in the central nervous system of the rat. J. comp. Neurol. 367:1996;375-402.
12. Drake C.T., Milner T.A. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res. 849:1999;203-215.
13. Drake C.T., Patterson T.A., Simmons M.L., Chavkin C., Milner T.A. Kappa opioid receptor-like immunoreactivity in guinea-pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation. J. comp. Neurol. 370:1996;377-395.
14. Eldred W.D., Zucker C., Karten H.J., Yazulla S. Comparison of fixation and penetration enhancement techniques for use in ultrastructural immunocytochemistry. J. Histochem. Cytochem. 31:1983;285-292.
15. Eppler C.M., Hulmes J.D., Wang J.-B., Johnson B., Corbett M., Luthin D.R., Uhl G.R., Linden J. Purification and partial amino acid sequence of a μ opioid receptor from rat brain. J. biol. Chem. 268:1993;26,447-26,451.
16. Giesler G.J., Cannon J.T., Urca G., Liebeskind J.C. Long ascending projections from substantia gelatinosa Rolandi and the subjacent dorsal horn in the rat. Science. 202:1978;984-986.
17. Giros B., Pohl M., Rochelle J.M., Seldin M.F. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sci. 56:1995;PL369-PL375.
18. Guan J.L., Wang Q.P., Nakai Y. Electron microscopic observation of μ-opioid receptor in the rat area postrema. Peptides. 20:1999;873-880.
19. Guiramand J., Montmayeur J.P., Ceraline J., Bhatia M., Borrelli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J. biol. Chem. 270:1995;7354-7358.
20. Hsu S.M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. clin. Path. 75:1981;734-738.
21. Lamotte C., Pert C.B., Snyder S.H. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res. 112:1976;407-412.
22. Liang Y., Mestek A., Yu L., Carr L.G. Cloning and characterization of the promoter region of the mouse μ opioid receptor gene. Brain Res. 679:1995;82-88.
23. Lima D., Coimbra A. Neurons in the substantia gelatinosa rolandi (lamina II) project to the caudal ventrolateral reticular formation of the medulla oblongata in the rat. Neurosci. Lett. 132:1991;16-18.
24. Lima D., Mendes-Ribeiro J.A., Coimbra A. The spino-latero-reticular system of the rat: projections from the superficial dorsal horn and structural characterization of marginal neurons involved. Neuroscience. 45:1991;137-152.
25. Llewellyn-Smith I.J., Minson J.B. Complete penetration of antibodies into Vibratome sections after glutaraldehyde fixation and ethanol treatment: light and electron microscopy for neuropeptides. J. Histochem. Cytochem. 40:1992;1741-1749.
26. Lucas J.J., Hen R. New players in the 5-HT receptor field: genes and knockouts. Trends pharmac. Sci. 16:1995;246-252.
27. Lupica C.R., Proctor W.R., Dunwiddie T.V. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Brain Res. 593:1992;226-238.
28. Madison D.V., Nicoll R.A. Enkephalin hyperpolarizes interneurones in the rat hippocampus. J. Physiol., Lond. 398:1988;123-130.
29. Maekawa K., Minami M., Yabuuchi K., Toya T., Katao Y., Hosoi Y., Onogi T., Satoh M. In situ hybridization study of μ- and κ-opioid receptor mRNAs in the rat spinal cord and dorsal root ganglia. Neurosci. Lett. 168:1994;97-100.
30. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS. J. chem. Neuroanat. 8:1995;283-305.
31. Mansour A., Hoversten M.T., Taylor L.P., Watson S.J., Akil H. The cloned μ, δ and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res. 700:1995;89-98.
32. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. comp. Neurol. 405:1999;450-471.
33. Martin-Schild S., Zadina J.E., Gerall A.A., Vigh S., Kastin A.J. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides. 18:1997;1641-1649.
34. Mayer P., Schulzeck S., Kraus J., Zimprich A., Höllt V. Promoter region and alternatively spliced exons of the rat μ-opioid receptor gene. J. Neurochem. 66:1996;2272-2278.
35. Mazarati A., Liu H., Wasterlain C. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus. Neuroscience. 89:1999;167-173.
36. Menetrey D., Chaouch A., Binder D., Besson J.M. The origin of the spinomesencephalic tract in the rat: an anatomical study using the retrograde transport of horseradish peroxidase. J. comp. Neurol. 206:1982;193-207.
37. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., Loh H.H. Genomic structure and analysis of promoter sequence of a mouse μ opioid receptor gene. Proc. natn. Acad. Sci. USA. 91:1994;9081-9085.
38. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 365:1993;166-170.
39. Nicoll R.A., Alger B.E., Jahr C.E. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature. 287:1980;22-25.
40. Pan Y.-X., Xu J., Bolan E.A., Chang A., Mahurter L., Rossi G.C., Pasternak G.W. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform MOR-1F. Fedn Eur. biochem. Socs Lett. 466:2000;337-340.
41. Pan Y.X., Xu J., Bolan E.A., Abbadie C., Chang A., Zuckerman A., Rossi G.C., Pasternak G.W. Identification and characterization of three new alternatively spliced mu opioid receptor isoforms. Molec. Pharmac. 56:1999;396-403.
42. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmac. 16:1993;1-18.
43. Pasternak G.W., Childers S.R., Snyder S.H. Naloxazone, long-acting opiate antagonist: effects in intact animals and on opiate receptor binding in vitro. J. Pharmac. exp. Ther. 214:1980;455-462.
44. Pasternak G.W., Childers S.R., Snyder S.H. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science. 208:1980;514-516.
45. Pasternak G.W., Snyder S.H. Identification of a novel high affinity opiate receptor binding in rat brain. Nature. 253:1975;563-565.
46. Pasternak G.W., Standifer K.M. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends pharmac. Sci. 16:1995;344-350.
47. Reisine T. and Pasternak G. W. (1996) Opioid analgesics and antagonists, In Goodman & Gilman's: The Pharmacological Basis of Therapeutics (eds Hardman J. G. and Limbird L. E.). McGraw-Hill, New York, pp. 521-556.
48. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 17:1963;208-212.
49. Rossi G.C., Pan Y.-X., Brown G.P., Pasternak G.W. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. Fedn Eur. biochem. Socs Lett. 369:1995;192-196.
50. Rossi G.C., Pan Y.-X., Cheng J., Pasternak G.W. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor. Life Sci. 54:1994;PL375-PL379.
51. Rossi G.C., Standifer K.M., Pasternak G.W. Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci. Lett. 198:1995;99-102.
52. Schulz S., Schreff M., Koch T., Zimprich A., Gramsch C., Elde R., Höllt V. Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience. 82:1998;613-622.
53. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J. Neurosci. 17:1997;2585-2594.
54. Svoboda K.R., Lupica C.R. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J. Neurosci. 18:1998;7084-7098.
55. Uhl G.R., Childers S., Pasternak G.W. An opiate-receptor gene family reunion. Trends Neurosci. 17:1994;89-93.
56. Van Bockstaele E.J., Saunders A., Telegan P., Page M.E. Localization of mu-opioid receptors to locus coeruleus-projecting neurons in the rostral medulla: morphological substrates and synaptic organization. Synapse. 34:1999;154-167.
57. Vanetti M., Kouba M., Wang X., Vogt G., Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). Fedn Eur. biochem. Socs Lett. 311:1998;290-294.
58. Wagner J.J., Evans C.J., Chavkin C. Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampus. J. Neurochem. 57:1991;333-343.
59. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. μ Opiate receptor: cDNA cloning and expression. Proc. natn. Acad. Sci. USA. 90:1993;10,230-10,234.
60. Wimpey T.L., Chavkin C. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron. 6:1991;281-289.
61. Zieglagansberger W., French E.D., Siggins G.R., Bloom F.E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science. 205:1979;415-417.
62. Zimprich A., Simon T., Hollt V. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR 1 B) which differs in agonist induced desensitization from rMOR1. Fedn Eur. biochem. Socs Lett. 359:1995;142-146.